| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047613144 |
| P356 | DOI | 10.1038/BJC.1987.238 |
| P932 | PMC publication ID | 2001894 |
| P698 | PubMed publication ID | 3426916 |
| P5875 | ResearchGate publication ID | 19729253 |
| P50 | author | Julian Downward | Q6307119 |
| David E. Neal | Q42941105 | ||
| P2093 | author name string | Berger MS | |
| Waterfield MD | |||
| Haley J | |||
| Harris AL | |||
| Gullick WJ | |||
| Greenfield C | |||
| P2860 | cites work | Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus | Q24339526 |
| Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
| Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets | Q33821869 | ||
| Autophosphorylation sites on the epidermal growth factor receptor. | Q34245370 | ||
| Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus | Q34254297 | ||
| Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line | Q34538847 | ||
| Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. | Q36592294 | ||
| Human squamous cell lung cancers express increased epidermal growth factor receptors | Q36993618 | ||
| The biochemistry and physiology of the receptor-kinase for epidermal growth factor | Q40136700 | ||
| Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function. | Q41427215 | ||
| Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas | Q41886819 | ||
| Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. | Q42811529 | ||
| Oncogenes and bladder cancer | Q42813662 | ||
| Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours | Q42818690 | ||
| Expression of epidermal growth factor receptors in human brain tumors | Q43510183 | ||
| High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. | Q43575226 | ||
| Clinical implications of oncogene activation in human neuroblastomas | Q44062780 | ||
| Expression of ras oncogene p21 in prostate cancer | Q44354411 | ||
| Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas | Q44590373 | ||
| Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein | Q44629218 | ||
| A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential | Q44889335 | ||
| Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin | Q48536258 | ||
| Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro. | Q53545513 | ||
| Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. | Q53554133 | ||
| Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. | Q53556700 | ||
| MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. | Q54451512 | ||
| Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease | Q68797034 | ||
| Structure and expression of the chicken epidermal growth factor receptor gene locus | Q69640150 | ||
| Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer | Q69856765 | ||
| Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours | Q69856767 | ||
| Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas | Q70101263 | ||
| Evidence for increased epidermal growth factor receptors in human sarcomas | Q70109920 | ||
| Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels | Q70222255 | ||
| In vivo amplification and rearrangement of the c-Ha-ras-1 sequence in a human bladder carcinoma | Q71184785 | ||
| Cellular localisation of human epidermal growth factor receptor | Q72392851 | ||
| Epidermal growth factor receptors in human breast cancer | Q72396557 | ||
| A monoclonal antibody to the human epidermal growth factor receptor | Q72695320 | ||
| Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes) | Q72722889 | ||
| Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas | Q93621132 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 533-537 | |
| P577 | publication date | 1987-11-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Evaluation of epidermal growth factor receptors in bladder tumours | |
| P478 | volume | 56 |
| Q42382564 | Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder |
| Q72581167 | An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseases |
| Q40653709 | Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants |
| Q35994375 | Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value |
| Q41580263 | Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines |
| Q41126348 | Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer |
| Q37960909 | Current treatment of metastatic bladder cancer and future directions |
| Q36536905 | Diagnostic utility of oncogenes and their products in human cancer |
| Q52552851 | Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. |
| Q41758031 | EGF stimulates anchorage-independent growth of a human bladder carcinoma cell line (KU1) with an amplified and over-expressed EGF receptor gene |
| Q41509778 | Effect of epidermal growth factor and transforming growth factor beta 1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines |
| Q55113730 | Effects of miR‑138‑5p and miR‑204‑5p on the migration and proliferation of gastric cancer cells by targeting EGFR. |
| Q35223249 | Epidermal growth factor and its receptor: Markers of— and targets for—chemoprevention of bladder cancer |
| Q55485775 | Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. |
| Q72597179 | Epidermal growth factor receptor expression in squamous cell lung carcinomas: an immunohistochemical and gene analysis in formalin-fixed, paraffin-embedded material |
| Q69743844 | Epidermal growth factor receptor in adenocarcinoma of the kidney |
| Q33315034 | Epidermal growth factor receptor structural alterations in gastric cancer |
| Q42814372 | Epidermal growth factor responsiveness of a new human neuroblastoma cell line |
| Q28365466 | Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase |
| Q46320350 | Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer |
| Q53461552 | Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: Comparison with dna ploidy |
| Q41651312 | Evaluation of the actions and interactions of retinoic acid and epidermal growth factor on transformed urothelial cells in culture: Implications for the use of retinoid therapy in the treatment of bladder cancer patients |
| Q31045910 | Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis |
| Q58271970 | Expression of Epidermal Growth Factor Receptor in Laryngeal Dysplasia and Carcinoma |
| Q35982167 | Expression of c-erbB-2 protein product in bladder cancer |
| Q67274369 | Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma |
| Q72314515 | Expression of epidermal growth factor receptor messenger RNA in human colorectal carcinomas assessed by non-radioactive in-situ hybridization |
| Q71988960 | Flow cytometric detection and quantitation of the epidermal growth factor receptor in comparison to Scatchard analysis in human bladder carcinoma cell lines |
| Q36467548 | Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck |
| Q37167213 | Growth Factor Receptors |
| Q35585541 | Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors |
| Q41442987 | Growth factors in bladder cancer |
| Q36588036 | Human epidermal growth factor receptor 2/neu overexpression in urothelial carcinoma of the bladder and its prognostic significance: Is it worth hype? |
| Q24318727 | Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells |
| Q74545010 | Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer |
| Q41475763 | In vitro and in vivo acceleration of the neoplastic phenotype of a low-tumorigenicity rat bladder carcinoma cell line by transfected transforming growth factor-alpha |
| Q35832669 | In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. |
| Q48176716 | Indium-111-labeled anti-EGFr-425 scintigraphy in the detection of malignant gliomas |
| Q53494341 | Inhibition of two-step urinary bladder carcinogenesis by the somatostatin analogue RC-160. |
| Q74226141 | Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2 |
| Q40998701 | Isolation and characterization of a novel bladder cancer cell line: inhibition by epidermal growth factor. |
| Q37827947 | Markers of bladder cancer State of the art. |
| Q24676403 | Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior |
| Q42441550 | Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor |
| Q68085236 | Molecular biology of bladder cancer |
| Q37909173 | Molecular biology of urological tumours. |
| Q72691766 | Molecular prognostic factors in bladder cancer |
| Q33851133 | Mutation of cell cycle regulators and their impact on superficial bladder cancer |
| Q35173073 | Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family |
| Q35817122 | Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder |
| Q38486301 | Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value |
| Q41718392 | Over-expression of the epidermal growth factor receptor in human breast cancer cells fails to induce an Estrogen-independent phenotype |
| Q54242436 | Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs). |
| Q70584624 | Prognostic significance of epidermal growth factor receptor in squamous cell carcinoma of the maxillary sinus |
| Q47771329 | Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications. |
| Q42590308 | Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer |
| Q41679383 | Protein tyrosine kinases and cancer |
| Q33565845 | Recent advances in treatment of advanced urothelial carcinoma |
| Q38481899 | Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer |
| Q42756305 | Relationship of epidermal growth factor receptor detectability with the A, B, H blood group antigens. Emphasis on normal and neoplastic urothelium |
| Q33942056 | Role of BMK1 in regulation of growth factor-induced cellular responses |
| Q39103374 | Sleeping beauty: awakening urothelium from its slumber |
| Q53797133 | The epidermal growth factor receptor and the prognosis of bladder cancer. |
| Q54143980 | The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer. |
| Q39991480 | Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor |
| Q35795090 | c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization |
Search more.